These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9154031)

  • 21. Improving anticoagulation control in hospitalized elderly patients on warfarin.
    Gouin-Thibault I; Levy C; Pautas E; Cambus JP; Drouet L; Mahé I; Bal Dit Sollier C; Horellou MH; Golmard JL; Siguret V
    J Am Geriatr Soc; 2010 Feb; 58(2):242-7. PubMed ID: 20374400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicentre randomised clinical endpoint study of PARMA 5 computer-assisted oral anticoagulant dosage.
    Poller L; Keown M; Ibrahim S; Lowe G; Moia M; Turpie AG; Roberts C; van den Besselaar AM; van der Meer FJ; Tripodi A; Palareti G; Jespersen J
    Br J Haematol; 2008 Oct; 143(2):274-83. PubMed ID: 18759767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Personalized versus non-personalized computerized decision support system to increase therapeutic quality control of oral anticoagulant therapy: an alternating time series analysis.
    Colombet I; Bura-Rivière A; Chatila R; Chatellier G; Durieux P;
    BMC Health Serv Res; 2004 Sep; 4(1):27. PubMed ID: 15456515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: randomised controlled trial.
    Thomson RG; Eccles MP; Steen IN; Greenaway J; Stobbart L; Murtagh MJ; May CR
    Qual Saf Health Care; 2007 Jun; 16(3):216-23. PubMed ID: 17545350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of anticoagulant treatment using a dynamic decision support algorithm: a Danish Cohort study.
    Nielsen PB; Lundbye-Christensen S; Rasmussen LH; Larsen TB
    Thromb Res; 2014 Mar; 133(3):375-9. PubMed ID: 24444650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Good quality of oral anticoagulation treatment in general practice using international normalised ratio point of care testing.
    Løkkegaard T; Pedersen TH; Lind B; Siersma V; Waldorff FB
    Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin K for improved anticoagulation control in patients receiving warfarin.
    Mahtani KR; Heneghan CJ; Nunan D; Roberts NW
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD009917. PubMed ID: 24832594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profile and anticoagulation outcomes of patients on warfarin therapy in an urban hospital in Cape Town, South Africa.
    Sonuga BO; Hellenberg DA; Cupido CS; Jaeger C
    Afr J Prim Health Care Fam Med; 2016 May; 8(1):e1-8. PubMed ID: 27247158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin. A randomised trial.
    Boonyawat K; Wang L; Lazo-Langner A; Kovacs MJ; Yeo E; Schnurr T; Schulman S; Crowther MA
    Thromb Haemost; 2016 Aug; 116(3):480-5. PubMed ID: 27346552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink.
    Macedo AF; Bell J; McCarron C; Conroy R; Richardson J; Scowcroft A; Sunderland T; Rotheram N
    Thromb Res; 2015 Aug; 136(2):250-60. PubMed ID: 26073321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introduction of computer assisted control of oral anticoagulation in general practice.
    Galloway MJ; Foggin JJ; Dixon S
    J Clin Pathol; 1995 Dec; 48(12):1144-6. PubMed ID: 8568006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.
    Sridhar VS; Leung P; Seymour N; Nagge J
    Can Fam Physician; 2014 Nov; 60(11):e535-40. PubMed ID: 25551135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program.
    Poller L; Keown M; Ibrahim S; Lowe G; Moia M; Turpie AG; Roberts C; van den Besselaar AM; van der Meer FJ; Tripodi A; Palareti G; Shiach C; Bryan S; Samama M; Burgess-Wilson M; Heagerty A; Maccallum P; Wright D; Jespersen J;
    Thromb Haemost; 2009 Mar; 101(3):487-94. PubMed ID: 19277410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States.
    Baker WL; Cios DA; Sander SD; Coleman CI
    J Manag Care Pharm; 2009 Apr; 15(3):244-52. PubMed ID: 19326955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated PRogram for Oral Anticoagulant Treatment).
    Manotti C; Moia M; Palareti G; Pengo V; Ria L; Dettori AG
    Haematologica; 2001 Oct; 86(10):1060-70. PubMed ID: 11602412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed discharges due to initiation of warfarin in atrial fibrillation: a prospective audit.
    Tan ES; Bonnett TJ; Abdelhafiz AH
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):232-5. PubMed ID: 17996662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Monitoring therapy with oral anticoagulants. Anticoagulation clinics vs assistant physician].
    Barreira R; Ribeiro J; Farinha M; Martins R; Rodrigues I; Mendes Z; Crespo F
    Acta Med Port; 2004; 17(6):413-6. PubMed ID: 16197852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of provision of time in therapeutic range value on anticoagulation management in atrial fibrillation patients on warfarin.
    Huang D; Wong CL; Cheng KW; Chan PH; Yue WS; Wong CK; Ho CW; Wong ICK; Chan EW; Siu CW
    Postgrad Med J; 2018 Apr; 94(1110):207-211. PubMed ID: 29459408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized trial of patient self-managed versus physician-managed oral anticoagulation.
    Sunderji R; Gin K; Shalansky K; Carter C; Chambers K; Davies C; Schwartz L; Fung A
    Can J Cardiol; 2004 Sep; 20(11):1117-23. PubMed ID: 15457308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.